• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, August 10, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

In Our DNA SC Now Available in Every South Carolina County

Bioengineer by Bioengineer
July 13, 2026
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A groundbreaking initiative out of the Medical University of South Carolina (MUSC) demonstrates the viability of large-scale genomic screening programs that transcend traditional healthcare boundaries. The study, recently published in JAMA Network Open, reveals how over 50,000 South Carolinians across all 46 counties—including those in medically underserved rural areas—have undergone no-cost genetic screening through the community-centric “In Our DNA SC” project. This extensive participation marks a significant advance in population-wide genomic equity.

Unlike conventional genetic tests aimed at patients with existing conditions or known family histories, this program proactively identifies genetic variations linked to serious but preventable diseases before symptoms manifest. The targeted conditions include hereditary breast and ovarian cancer syndrome, Lynch syndrome, and familial hypercholesterolemia—each known to dramatically elevate cancer or cardiovascular disease risks yet are amendable to early interventions.

The program’s design capitalizes on flexible sampling options such as blood draws at MUSC clinics, community-based specimen collection events, and remote testing via at-home cheek swabs. By minimizing logistical barriers and partnering with grassroots organizations, the researchers engineered a model grounded in implementation science principles that successfully penetrated rural and socially vulnerable demographics.

Epidemiologically, about one in every 65 screened individuals carries a pathogenic variant linked to one of the three diseases. Identified participants are promptly offered genetic counseling to interpret findings and facilitate tailored preventive care, including earlier cancer screenings or cholesterol management pharmacotherapy. Beyond individual care, anonymized data feeds an evolving database for refining precision medicine strategies.

Importantly, the study confirms equitable reach across geographic and socioeconomic divides, verified by adjusting participation rates against county population sizes, rurality metrics, and Centers for Disease Control and Prevention social vulnerability indices. However, it also highlights continued opportunities to boost engagement in the most remote communities.

“The ability to extend genomic screening outside academic medical centers and into diverse, rural populations is a pivotal step toward health equity,” explained Dr. Kalyani Sonawane, MUSC’s assistant director of data science and analytics. Dr. Daniel Judge, principal investigator and director of MUSC’s Cardiovascular Genetics Program, emphasized the life-saving potential, noting that early detection empowers preventative interventions that could reduce South Carolina’s leading causes of death—cancer and heart disease.

This pioneering research underscores the necessity of cultivating trust through community partnerships and educational outreach to mitigate apprehensions about genetic risk information. Looking ahead, the MUSC team plans to evaluate the long-term health outcomes of those screened, assessing the program’s efficacy in translating genomic insights into tangible reductions in disease burden.

As population-wide genomic screening gains momentum, initiatives like In Our DNA SC illuminate pathways for integrating genetic medicine into public health, promising a future where inherited risks are no longer a silent threat but a call to proactive care.

Subject of Research: People
Article Title: Geographic and social equity in population-wide genomic screening
News Publication Date: 13-Jul-2026
Web References: http://dx.doi.org/10.1001/jamanetworkopen.2026.22743
Keywords: Genetic screening, Genomics, Population genetics, Cancer genomics, Genetic testing, Hypercholesterolemia, Cancer screening, Cancer genetics

Tags: addressing health disparities in rural areasat-home genetic testing methodscommunity-based genetic testingearly detection of hereditary diseasesgenomic screening programshereditary cancer and cardiovascular riskimplementation science in healthcarelarge-scale genetic screening studiesMUSC genetic research projectspopulation-wide genetic testingrural health equitySouth Carolina healthcare initiatives

Share12Tweet7Share2ShareShareShare1

Related Posts

How Neuroblastoma Balances Replication Stress and Genome Stability Across Chromosome 17q

August 9, 2026

Cigar, Cigarillo, and Pipe Smoking: Lung Cancer Risk and Screening Eligibility

August 9, 2026

Study Explores PDLIM2 as Prognostic Biomarker and Treatment Target in Lung Adenocarcinoma

August 9, 2026

Neutrophil-Released S100A8/A9 Activates Reparative Macrophages, Delaying Denervated Muscle Atrophy

August 8, 2026

POPULAR NEWS

  • How Neuroblastoma Balances Replication Stress and Genome Stability Across Chromosome 17q

    29 shares
    Share 12 Tweet 7
  • Cigar, Cigarillo, and Pipe Smoking: Lung Cancer Risk and Screening Eligibility

    29 shares
    Share 12 Tweet 7
  • How Low Gravity and Pressure Affect Space Manufacturing of Carbon-Fiber Structures

    29 shares
    Share 12 Tweet 7
  • Calreticulin-targeted L-asparaginase–flagellin conjugate boosts Salmonella’s antitumor effectiveness

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

How Neuroblastoma Balances Replication Stress and Genome Stability Across Chromosome 17q

Cigar, Cigarillo, and Pipe Smoking: Lung Cancer Risk and Screening Eligibility

How Low Gravity and Pressure Affect Space Manufacturing of Carbon-Fiber Structures

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 86 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.